Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.

Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL.

J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S69-77. doi: 10.1016/j.jaad.2011.04.033.

2.

Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.

Balamurugan A, Ahmed F, Saraiya M, Kosary C, Schwenn M, Cokkinides V, Flowers L, Pollack LA.

Cancer. 2008 Nov 15;113(10 Suppl):2919-25. doi: 10.1002/cncr.23746.

3.

Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.

Spanogle JP, Clarke CA, Aroner S, Swetter SM.

J Am Acad Dermatol. 2010 May;62(5):757-67. doi: 10.1016/j.jaad.2009.07.039.

PMID:
20223559
4.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
5.

Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.

Hemminki K, Dong C.

Arch Dermatol. 2000 May;136(5):647-51.

PMID:
10815858
6.

Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.

Goggins WB, Finkelstein DM, Tsao H.

Cancer. 2001 Feb 15;91(4):874-80.

PMID:
11241258
7.

Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.

Whorton MD, Moore DN, Seward JP, Noonan KA, Mendelsohn ML.

Am J Ind Med. 2004 Jan;45(1):24-33.

PMID:
14691966
8.
9.

Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.

Frisch M, Hjalgrim H, Olsen JH, Melbye M.

Ann Intern Med. 1996 Nov 15;125(10):815-21.

PMID:
8928988
10.

Merkel cell carcinoma: incidence, mortality, and risk of other cancers.

Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, Melbye M.

J Natl Cancer Inst. 2010 Jun 2;102(11):793-801. doi: 10.1093/jnci/djq120.

PMID:
20424236
11.

Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

Adami J, Frisch M, Yuen J, Glimelius B, Melbye M.

BMJ. 1995 Jun 10;310(6993):1491-5.

12.

Second cancers in patients with chronic lymphocytic leukemia.

Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr.

J Natl Cancer Inst. 1992 Sep 16;84(18):1422-7.

PMID:
1512794
13.

Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.

van der Leest RJ, Liu L, Coebergh JW, Neumann HA, Mooi WJ, Nijsten T, de Vries E.

Br J Dermatol. 2012 Dec;167(6):1321-30. doi: 10.1111/j.1365-2133.2012.11123.x.

PMID:
22759226
14.

The association between malignant melanoma and noncutaneous malignancies.

Wu YH, Kim GH, Wagner JD, Hood AF, Chuang TY.

Int J Dermatol. 2006 May;45(5):529-34.

PMID:
16700785
15.

Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.

Ahmed F, Goodman MT, Kosary C, Ruiz B, Wu XC, Chen VW, Correa CN.

Cancer. 2006 Sep 1;107(5 Suppl):1162-71.

16.

Risk-adjusted melanoma skin cancer incidence rates in Whites (United States).

Merrill RM.

Melanoma Res. 2011 Dec;21(6):535-40. doi: 10.1097/CMR.0b013e328349420f.

PMID:
21730876
17.

Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.

Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia KS, Tonita JM, Jonasson JG, Boffetta P, Brennan P.

Eur J Cancer. 2007 Jul;43(11):1701-12.

PMID:
17540555
18.

Incidence of invasive cancers following basal cell skin cancer.

Levi F, La Vecchia C, Te VC, Randimbison L, Erler G.

Am J Epidemiol. 1998 Apr 15;147(8):722-6.

PMID:
9554413
19.

Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.

Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC.

Int J Dermatol. 2015 Aug;54(8):e287-93. doi: 10.1111/ijd.12564.

PMID:
25772131
20.

Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.

Yang GB, Barnholtz-Sloan JS, Chen Y, Bordeaux JS.

Arch Dermatol. 2011 Dec;147(12):1395-402. doi: 10.1001/archdermatol.2011.1133.

PMID:
22184761
Items per page

Supplemental Content

Support Center